Role of Krüppel-like factor 4 and its binding proteins in vascular disease

Tadashi Yoshida1, Matsuhiko Hayashi

  • 1Apheresis and Dialysis Center, School of Medicine, Keio University.

Insights

Krüppel-like factor 4 (KLF4) influences vascular diseases by regulating genes in smooth muscle cells and endothelial cells. Understanding KLF4’s role is key to developing new treatments for vascular conditions.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Cell Biology

Background:

  • Krüppel-like factor 4 (KLF4) is a transcription factor crucial for cell development.
  • KLF4 is present in vascular cells like smooth muscle cells (SMCs), endothelial cells, and macrophages.
  • KLF4 dysregulation is implicated in various diseases, including cancer and vascular pathologies.

Purpose of the Study:

  • To summarize the role of KLF4 in vascular disease.
  • To focus on in vivo studies investigating KLF4's function in the vasculature.
  • To review the regulatory mechanisms of KLF4-mediated gene transcription in vascular contexts.

Main Methods:

  • Review of in vivo studies on KLF4 in vascular disease.
  • Analysis of KLF4's interactions with partner proteins (e.g., SRF, ELK1, p53, RUNX2, NF-κB).
  • Examination of KLF4's effects on gene expression in vascular cells.

Main Results:

  • KLF4 modulates SMC differentiation and proliferation through interactions with SRF, ELK1, and p53.
  • KLF4 promotes arterial medial calcification in conjunction with RUNX2.
  • Endothelial KLF4 suppresses arterial inflammation by inhibiting nuclear factor-κB (NF-κB) signaling.

Conclusions:

  • KLF4 plays a multifaceted role in vascular disease progression.
  • KLF4's interactions with various proteins dictate its function in different vascular cell types.
  • Further research into KLF4 regulatory mechanisms is essential for therapeutic development in vascular diseases.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.0K
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
2.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.9K